In conclusion, IL-12 may not be the biomarker of choice for diagnosis and screening of early BC, nonetheless it should be considered as potential prognostic markers, especially in combination with other prognostic markers like MMP9, TIMP1, CEA and CA in early BC patients. The gene discussed is TIMP1; the disease is breast cancer.